With about 2.4 million people on antiretroviral therapy (ART) and more than 300,000 people treated for tuberculosis (TB) every year, South Africa has the largest HIV treatment programme in the world and an enormous associated TB treatment programme.

Ensuring regular and uninterrupted supply of antiretroviral (ARVs) and TB medicines is critical for its success.

To quantify the extent of ARV, TB and vaccine stock outs at the provincial and national level, the Stop Stock Outs Project undertook a national telephonic survey between September and October 2013.

The project is a joint effort by organizations including Medicines Sans Frontieres, the Treatment Action Campaign and the Southern African HIV Clinicians’ Society.

Stock outs in South Africa – a national crisis